Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tally Health

Request full access

Tally Health‚Ñ¢ is a biotechnology company founded to change the way we age. Co-founded by longevity expert Dr. David Sinclair

New York City, United StatesFounded 2021Biotech & Life Sciences

About Tally Health

Tally Health is a consumer biotechnology company operating in the burgeoning longevity and wellness market, which launched in February 2023. The company was co-founded by Dr. David Sinclair, a prominent Harvard Medical School genetics professor and expert on aging, and Whitney Casey, a serial entrepreneur and partner at L Catterton, the private equity firm that incubated and initially backed the firm. The company is led by CEO Melanie Goldey, a seasoned executive with a background in health-tech and finance, having held leadership roles at TMRW Life Sciences, Refinery29, and Everyday Health Group.

Tally Health's business model is centered on a direct-to-consumer membership platform designed to provide individuals with tools to manage their cellular aging. Revenue is generated through monthly subscriptions which provide members with quarterly at-home epigenetic age tests, personalized lifestyle recommendations, and a daily longevity supplement. The core product is the TallyAge™ test, an at-home, non-invasive cheek swab test that analyzes DNA methylation to determine a user's biological age, as opposed to their chronological age. This test is based on a proprietary machine learning model trained on a diverse dataset of over 8,000 samples. Based on the test results and a lifestyle questionnaire, the platform delivers personalized, actionable recommendations for diet, fitness, sleep, and mental health aimed at lowering the user's TallyAge™. All members receive a daily supplement, with options like 'Vitality' and 'Restore', which contain compounds designed to support cellular health and defense mechanisms.

The company's scientific foundation is rooted in Dr. Sinclair's research, particularly the "Information Theory of Aging," which posits that aging is driven by epigenetic changes that disrupt cellular function over time. Tally Health secured a $10 million seed funding round in April 2023, led by Forerunner Ventures, with participation from L Catterton, G9 Ventures, Second Sight Ventures, and a roster of celebrity investors. This capital is being used to expand research and development, enhance the digital member experience, and scale business operations. The company targets the consumer wellness market, which is projected to grow significantly, by offering a science-backed approach to healthspan and longevity.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
15
Open positions
None listed
Dealroom signal
55.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, Longevity, DT and LS, science-based
Client focus
B2C

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Apr 2026 $0 — Infinite Epigenetics ↗
SEEDOther financing Apr 2023 $10M $40M Shonda Rhimes · John Legend · G9 Ventures · Rich Roll ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Tally Health website traffic

Latest recorded traffic for Tally Health is 45K monthly website visits, up 200% over the last three months. Tally Health's team declined 6.3% over the past year.

Latest monthly visits45K 3-month web change+200% 1-year team growth-6.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tally Health in the New York City ecosystem

Live from Dealroom

The Tally Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed10 investors entered at this stage

  • Forerunner Ventures
  • Shonda Rhimes
  • John Legend
  • G9 Ventures
  • Rich Roll
  • L Catterton
  • Whitney Cummings
  • Kevin Hart
  • Second Sight Ventures
  • Chrissy Teigen

Other known investors2 additional known investors

  • Harvard Medical School
  • Infinite Epigenetics
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States87.5%
🇮🇳 India12.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tally Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tally Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.